मिडोड्रिन के इंटरैक्शन

हम जिन FDA लेबल और फैक्ट शीट को इंडेक्स करते हैं, उनमें मिडोड्रिन (ProAmatine, Orvaten; अल्फा-एड्रीनर्जिक एगोनिस्ट) के 140 इंटरैक्शन दर्ज हैं: 31 गंभीर, 49 मध्यम, 60 मामूली, और 0 ऐसे जिनमें लेबल बताता है कि कोई महत्वपूर्ण इंटरैक्शन नहीं है। नीचे की हर प्रविष्टि उस वाक्य को उद्धृत करती है जिस पर वह आधारित है। दवा का यह पेज एक शुरुआती बिंदु है, आपकी स्थिति के लिए कोई फ़ैसला नहीं।

लेबल से लिए गए इंटरैक्शन

गंभीर इंटरैक्शन (31)

  • आइसोनियाज़िडएंटीबायोटिकगंभीर

    Avoid use of MAO inhibitors or linezolid with midodrine. (मिडोड्रिन लेबल, दवाओं के इंटरैक्शन)

  • आरफॉर्मोटेरोलबीटा-एड्रीनर्जिक एगोनिस्टगंभीर

    Excessive Use of Arformoterol Tartrate Inhalation Solution and Use with Other Long-Acting Beta2-Agonists Fatalities have been reported in association with excessive use of inhaled sympathomimetic drugs. (आरफॉर्मोटेरोल लेबल, चेतावनियां और सावधानियां)

  • इप्राट्रोपियम और सैल्बुटामोलएंटीकोलिनर्जिकगंभीर

    DO NOT EXCEED RECOMMENDED DOSE Fatalities have been reported in association with excessive use of inhaled products containing sympathomimetic amines and with the home use of nebulizers. (इप्राट्रोपियम और सैल्बुटामोल लेबल, चेतावनियां)

  • इमिप्रामिनट्राइसाइक्लिक एंटीडिप्रेसेंटगंभीर

    Avoid the use of preparations, such as decongestants and local anesthetics, that contain any sympathomimetic amine (e.g., epinephrine, norepinephrine), since it has been reported that tricyclic antidepressants can potentiate the effects of catecholamines. (इमिप्रामिन लेबल, दवाओं के इंटरैक्शन)

  • कोकेनलोकल एनेस्थेटिकगंभीर

    Known Hypersensitivity or Idiosyncrasy to the Sympathomimetic Amines NUMBRINO is contraindicated in patients with a known history of hypersensitivity to cocaine or to the components of the nasal solution. (कोकेन लेबल, चेतावनियां और सावधानियां)

  • क्लोरोप्रोकेनलोकल एनेस्थेटिकगंभीर

    Vasopressors should not be used in the presence of ergot-type oxytocic drugs, since a severe persistent hypertension may occur. (क्लोरोप्रोकेन लेबल, चेतावनियां)

  • टरब्यूटालिनबीटा-एड्रीनर्जिक एगोनिस्टगंभीर

    Hypersensitivity Terbutaline sulfate is contraindicated in patients known to be hypersensitive to sympathomimetic amines or any component of this drug product. (टरब्यूटालिन लेबल, निषेध (कॉन्ट्राइंडिकेशन))

  • टिज़ानिडिनमसल रिलैक्सेंटगंभीर

    Hypotension: monitor for signs and symptoms of hypotension, in particular in patients receiving concurrent antihypertensives; Zanaflex should not be used with other α 2 -adrenergic agonists ( 5.1 , 7.7 ) (टिज़ानिडिन लेबल, चेतावनियां और सावधानियां)

  • ट्रैनिलसाइप्रोमिनMAO इनहिबिटरगंभीर

    Avoid use of MAO inhibitors or linezolid with midodrine. (मिडोड्रिन लेबल, दवाओं के इंटरैक्शन)

  • डेक्सट्रोएम्फेटामाइनCNS स्टिमुलेंटगंभीर

    CONTRAINDICATIONS Advanced arteriosclerosis, symptomatic cardiovascular disease, moderate to severe hypertension, hyperthyroidism, known hypersensitivity or idiosyncrasy to the sympathomimetic amines, glaucoma. (डेक्सट्रोएम्फेटामाइन लेबल, निषेध (कॉन्ट्राइंडिकेशन))

  • ड्रोनाबिनोलकैनाबिनॉइडगंभीर

    Avoid concomitant use of other drugs that are also associated with similar cardiac effects (e.g., amphetamines, other sympathomimetic agents, atropine, amoxapine, scopolamine, antihistamines, other anticholinergic agents, amitriptyline, desipramine, other tricyclic antidepressants). (ड्रोनाबिनोल लेबल, चेतावनियां और सावधानियां)

  • Vasopressors and resuscitation equipment should be immediately available in case of a severe reaction to protamine. (प्रोटामिन लेबल, बॉक्स्ड चेतावनी)

  • प्रोमेथाज़िनएंटीहिस्टामिनगंभीर

    Epinephrine Because of the potential for Promethazine to reverse epinephrine's vasopressor effect, epinephrine should NOT be used to treat hypotension associated with Promethazine Syrup overdose. (प्रोमेथाज़िन लेबल, दवाओं के इंटरैक्शन)

  • Epinephrine – Because of the potential for promethazine to reverse epinephrine’s vasopressor effect, epinephrine should NOT be used to treat hypotension associated with Promethazine Hydrochloride and Dextromethorphan Hydrobromide Oral Solution overdose. (प्रोमेथाज़िन और डेक्सट्रोमेथॉर्फन लेबल, दवाओं के इंटरैक्शन)

  • फेंटरमिन और टोपिरामेटCNS स्टिमुलेंटगंभीर

    …(8.1) ] With glaucoma [see Warnings and Precautions (5.3) ] With hyperthyroidism Taking or within 14 days of stopping a monoamine oxidase inhibitors [see Drug Interactions (7) ] With known hypersensitivity to phentermine, topiramate or any of the excipients in phentermine and topiramate extended-release capsules, or idiosyncrasy to the sympathomimetic amines. (फेंटरमिन और टोपिरामेट लेबल, निषेध (कॉन्ट्राइंडिकेशन))

  • फेनेलज़िनMAO इनहिबिटरगंभीर

    Avoid use of MAO inhibitors or linezolid with midodrine. (मिडोड्रिन लेबल, दवाओं के इंटरैक्शन)

  • फॉर्मोटेरोलबीटा-एड्रीनर्जिक एगोनिस्टगंभीर

    The increased risk of asthma-related death is considered a class effect of the long-acting beta 2 -adrenergic agonists, including formoterol fumarate inhalation solution. (फॉर्मोटेरोल लेबल, चेतावनियां और सावधानियां)

  • फ्लुटिकासोन और सैल्मेटेरोलकॉर्टिकोस्टेरॉइडगंभीर

    When LABA are used in fixed-dose combination with ICS, data from large clinical trials do not show a significant increase in the risk of serious asthma-related events (hospitalizations, intubations, death) compared with ICS alone [see Serious Asthma-Related Events with Inhaled Corticosteroid/Long-acting Beta 2 -adrenergic Agonists] . (फ्लुटिकासोन और सैल्मेटेरोल लेबल, चेतावनियां और सावधानियां)

  • बुडेसोनाइड और फॉर्मोटेरोलकॉर्टिकोस्टेरॉइडगंभीर

    Clinically significant cardiovascular effects and fatalities have been reported in association with excessive use of inhaled sympathomimetic drugs. (बुडेसोनाइड और फॉर्मोटेरोल लेबल, चेतावनियां और सावधानियां)

  • मिथाइलीन ब्लूMAO इनहिबिटरगंभीर

    Avoid use of MAO inhibitors or linezolid with midodrine. (मिडोड्रिन लेबल, दवाओं के इंटरैक्शन)

  • मेपिवाकेनलोकल एनेस्थेटिकगंभीर

    Mepivacaine with epinephrine or other vasopressors should not be used concomitantly with ergot-type oxytocic drugs, because a severe persistent hypertension may occur. (मेपिवाकेन लेबल, चेतावनियां)

  • यूमेक्लिडिनियम और विलैंटेरोलएंटीकोलिनर्जिकगंभीर

    • use of a long-acting beta 2 -adrenergic agonist (LABA), including vilanterol, one of the active ingredients in Umeclidinium and Vilanterol ELLIPTA, without an inhaled corticosteroid (ICS), in patients with asthma [see Warnings and Precautions ( 5.1 )] . (यूमेक्लिडिनियम और विलैंटेरोल लेबल, निषेध (कॉन्ट्राइंडिकेशन))

  • रासाजिलिनMAO इनहिबिटरगंभीर

    Avoid use of MAO inhibitors or linezolid with midodrine. (मिडोड्रिन लेबल, दवाओं के इंटरैक्शन)

  • लिनेज़ोलिडएंटीबायोटिकगंभीर

    Avoid use of MAO inhibitors or linezolid with midodrine. (मिडोड्रिन लेबल, दवाओं के इंटरैक्शन)

  • लियोथायरोनिनथायरॉइड हार्मोनगंभीर

    • Larger doses may produce serious or even life-threatening manifestations of toxicity, particularly when given in association with sympathomimetic amines such as those used for their anorectic effects [see Adverse Reactions (6) , Drug Interactions (7.7) , and Overdosage (10) ] . (लियोथायरोनिन लेबल, बॉक्स्ड चेतावनी)

  • लेवोथायरोक्सिन और लियोथायरोनिनथायरॉइड हार्मोनगंभीर

    Larger doses may produce serious or even life-threatening manifestations of toxicity, particularly when given in association with sympathomimetic amines such as those used for their anorectic effects. (लेवोथायरोक्सिन और लियोथायरोनिन लेबल, बॉक्स्ड चेतावनी)

  • लेवोसैल्बुटामोलबीटा-एड्रीनर्जिक एगोनिस्टगंभीर

    Do Not Exceed Recommended Dose Fatalities have been reported in association with excessive use of inhaled sympathomimetic drugs in patients with asthma. (लेवोसैल्बुटामोल लेबल, चेतावनियां और सावधानियां)

  • सेलेजिलिनMAO इनहिबिटरगंभीर

    Avoid use of MAO inhibitors or linezolid with midodrine. (मिडोड्रिन लेबल, दवाओं के इंटरैक्शन)

  • सैल्बुटामोलबीटा-एड्रीनर्जिक एगोनिस्टगंभीर

    Do Not Exceed Recommended Dose Fatalities have been reported in association with excessive use of inhaled sympathomimetic drugs in patients with asthma. (सैल्बुटामोल लेबल, चेतावनियां और सावधानियां)

  • सैल्मेटेरोलबीटा-एड्रीनर्जिक एगोनिस्टगंभीर

    WARNING: ASTHMA-RELATED DEATH Long-acting beta 2 -adrenergic agonists (LABA), such as salmeterol, the active ingredient in SEREVENT DISKUS, as monotherapy (without inhaled corticosteroids [ICS]) increase the risk of asthma-related death. (सैल्मेटेरोल लेबल, बॉक्स्ड चेतावनी)

  • • Hyaluronidase should not be used to enhance the absorption and dispersion of dopamine and/or alpha agonist drugs ( 7.2 ) (हायल्यूरोनिडेज़ लेबल, दवाओं के इंटरैक्शन)

मध्यम इंटरैक्शन (49)

  • इंसुलिन एस्पार्टइंसुलिनमध्यम

    …Insulin Aspart Drugs: Atypical antipsychotics (e.g., olanzapine and clozapine), corticosteroids, danazol, diuretics, estrogens, glucagon, isoniazid, niacin, oral contraceptives, phenothiazines, progestogens (e.g., in oral contraceptives), protease inhibitors, somatropin, sympathomimetic agents (e.g., albuterol, epinephrine, terbutaline), and thyroid hormones. (इंसुलिन एस्पार्ट लेबल, दवाओं के इंटरैक्शन)

  • इंसुलिन ग्लार्जिनइंसुलिनमध्यम

    …Glargine-yfgn Drugs: Atypical antipsychotics (e.g., olanzapine and clozapine), corticosteroids, danazol, diuretics, estrogens, glucagon, isoniazid, niacin, oral contraceptives, phenothiazines, progestogens (e.g., in oral contraceptives), protease inhibitors, somatropin, sympathomimetic agents (e.g., albuterol, epinephrine, terbutaline), and thyroid hormones. (इंसुलिन ग्लार्जिन लेबल, दवाओं के इंटरैक्शन)

  • इंसुलिन डेग्लुडेकइंसुलिनमध्यम

    …Insulin Degludec Drugs: Atypical antipsychotics (e.g., olanzapine and clozapine), corticosteroids, danazol, diuretics, estrogens, glucagon, isoniazid, niacin, oral contraceptives, phenothiazines, progestogens (e.g., in oral contraceptives), protease inhibitors, somatropin, sympathomimetic agents (e.g., albuterol, epinephrine, terbutaline), and thyroid hormones. (इंसुलिन डेग्लुडेक लेबल, दवाओं के इंटरैक्शन)

  • इंसुलिन डेटेमिरइंसुलिनमध्यम

    …Effect of LEVEMIR Drugs: Atypical antipsychotics (e.g., olanzapine and clozapine), corticosteroids, danazol, diuretics, estrogens, glucagon, isoniazid, niacin, oral contraceptives, phenothiazines, progestogens (e.g., in oral contraceptives), protease inhibitors, somatropin, sympathomimetic agents (e.g., albuterol, epinephrine, terbutaline), and thyroid hormones. (इंसुलिन डेटेमिर लेबल, दवाओं के इंटरैक्शन)

  • इंसुलिन लिस्प्रोइंसुलिनमध्यम

    …Effect of LYUMJEV Drugs: Atypical antipsychotics (e.g., olanzapine and clozapine), corticosteroids, danazol, diuretics, estrogens, glucagon, isoniazid, niacin, oral contraceptives, phenothiazines, progestogens (e.g., in oral contraceptives), protease inhibitors, somatropin, sympathomimetic agents (e.g., albuterol, epinephrine, terbutaline), and thyroid hormones. (इंसुलिन लिस्प्रो लेबल, दवाओं के इंटरैक्शन)

  • एक्लिडिनियमएंटीकोलिनर्जिकमध्यम

    Sympathomimetics, Methylxanthines, Steroids In clinical studies, concurrent administration of aclidinium bromide and other drugs commonly used in the treatment of COPD including sympathomimetics (short-acting beta 2 agonists), methylxanthines, and oral and inhaled steroids showed no increases in adverse drug reactions. (एक्लिडिनियम लेबल, दवाओं के इंटरैक्शन)

  • एफेड्रिनसिम्पैथोमिमेटिकमध्यम

    The risk of hypertension increases with concomitant administration of drugs that increase blood pressure (phenylephrine, pseudoephedrine, ephedrine, dihydroergotamine, thyroid hormones, or droxidopa). (मिडोड्रिन लेबल, दवाओं के इंटरैक्शन)

  • एमिट्रिप्टिलीनट्राइसाइक्लिक एंटीडिप्रेसेंटमध्यम

    When amitriptyline is given with anticholinergic agents or sympathomimetic drugs, including epinephrine combined with local anesthetics, close supervision and careful adjustment of dosages are required. (एमिट्रिप्टिलीन लेबल, दवाओं के इंटरैक्शन)

  • एमियोडेरोनएंटीएरिदमिकमध्यम

    • Hypotension: Slow the infusion; as needed, add vasopressor drugs, positive inotropic agents, and volume expansion. (एमियोडेरोन लेबल, चेतावनियां और सावधानियां)

  • एम्फेटामाइनCNS स्टिमुलेंटमध्यम

    Tricyclic Antidepressants Clinical Impact May enhance the activity of tricyclic or sympathomimetic agents causing striking and sustained increases in the concentration of d- amphetamine in the brain; cardiovascular effects can be potentiated. (एम्फेटामाइन लेबल, दवाओं के इंटरैक्शन)

  • Tricyclic Antidepressants Clinical Impact May enhance the activity of tricyclic or sympathomimetic agents causing striking and sustained increases in the concentration of d-amphetamine in the brain; cardiovascular effects can be potentiated. (एम्फेटामाइन और डेक्सट्रोएम्फेटामाइन लेबल, दवाओं के इंटरैक्शन)

  • Examples: Thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs and isoniazid Alogliptin Cytochrome (CYP) P450, CYP-Substrates or Inhibitors Clinical Impact: Insulin Secretagogues and Insulin Insulin and insulin secretagogues… (एलोग्लिप्टिन और मेटफॉर्मिन लेबल, दवाओं के इंटरैक्शन)

  • एस्मोलोलबीटा ब्लॉकरमध्यम

    Sympathomimetic drugs: Dose adjustment needed (7) (एस्मोलोल लेबल, दवाओं के इंटरैक्शन)

  • केटामिनCNS डिप्रेसेंटमध्यम

    Sympathomimetics and Vasopressin : Sympathomimetics and vasopressin may enhance the sympathomimetic effects of ketamine [see Drug Interactions ( 7.2 )] . (केटामिन लेबल, चेतावनियां और सावधानियां)

  • कैंडेसार्टनएंजियोटेंसिन II रिसेप्टर ब्लॉकर (ARB)मध्यम

    Very rarely, hypotension may be severe such that it may warrant the use of intravenous fluids and/or vasopressors. (कैंडेसार्टन लेबल, चेतावनियां और सावधानियां)

  • क्लोमिप्रामिनट्राइसाइक्लिक एंटीडिप्रेसेंटमध्यम

    Close supervision and careful adjustment of dosage are required when clomipramine hydrochloride capsules are administered with anticholinergic or sympathomimetic drugs. (क्लोमिप्रामिन लेबल, दवाओं के इंटरैक्शन)

  • ग्लिपिज़ाइडसल्फोनिलयूरियामध्यम

    …olanzapine and clozapine), corticosteroids, danazol, diuretics, estrogens, glucagon, isoniazid, niacin, oral contraceptives, phenothiazines, progestogens (e.g., in oral contraceptives), protease inhibitors, somatropin, sympathomimetic agents (e.g., albuterol, epinephrine, terbutaline), thyroid hormones, phenytoin, nicotinic acid, and calcium channel blocking drugs. (ग्लिपिज़ाइड लेबल, दवाओं के इंटरैक्शन)

  • ग्लिमेपिराइडसल्फोनिलयूरियामध्यम

    …somatropin, protease inhibitors, atypical antipsychotic medications (e.g., olanzapine and clozapine), barbiturates, diazoxide, laxatives, rifampin, thiazides and other diuretics, corticosteroids, phenothiazines, thyroid hormones, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics (e.g., epinephrine, albuterol, terbutaline), and isoniazid. (ग्लिमेपिराइड लेबल, दवाओं के इंटरैक्शन)

  • टिमोलोलबीटा ब्लॉकरमध्यम

    If necessary during surgery, the effects of beta-adrenergic blocking agents may be reversed by sufficient doses of adrenergic agonists. (टिमोलोल लेबल, चेतावनियां और सावधानियां)

  • टियोट्रोपियमएंटीकोलिनर्जिकमध्यम

    Concomitant Respiratory Medications SPIRIVA RESPIMAT has been used concomitantly with short-acting and long-acting sympathomimetic (beta-agonists) bronchodilators, methylxanthines, oral and inhaled steroids, antihistamines, mucolytics, leukotriene modifiers, cromones, and anti-IgE treatment without increases in adverse reactions. (टियोट्रोपियम लेबल, दवाओं के इंटरैक्शन)

  • टेरिपैराटाइडथायरॉइड हार्मोनमध्यम

    The risk of hypertension increases with concomitant administration of drugs that increase blood pressure (phenylephrine, pseudoephedrine, ephedrine, dihydroergotamine, thyroid hormones, or droxidopa). (मिडोड्रिन लेबल, दवाओं के इंटरैक्शन)

  • Drugs That Increase Catecholamines: Tolcapone did not influence the effect of ephedrine, an indirect sympathomimetic, on hemodynamic parameters or plasma catecholamine levels, either at rest or during exercise. (टोलकैपोन लेबल, दवाओं के इंटरैक्शन)

  • डाइसाइक्लोमिनएंटीकोलिनर्जिकमध्यम

    …drugs including dicyclomine hydrochloride: amantadine, antiarrhythmic agents of Class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity. (डाइसाइक्लोमिन लेबल, दवाओं के इंटरैक्शन)

  • डाइहाइड्रोएर्गोटामिनएर्गोट एल्कलॉइडमध्यम

    The risk of hypertension increases with concomitant administration of drugs that increase blood pressure (phenylephrine, pseudoephedrine, ephedrine, dihydroergotamine, thyroid hormones, or droxidopa). (मिडोड्रिन लेबल, दवाओं के इंटरैक्शन)

  • डिगॉक्सिनडिजिटेलिस ग्लाइकोसाइडमध्यम

    Drug Interactions: When administered concomitantly with midodrine hydrochloride, cardiac glycosides may enhance or precipitate bradycardia, A.V. block or arrhythmia. (मिडोड्रिन लेबल, दवाओं के इंटरैक्शन)

  • डेसिप्रामिनट्राइसाइक्लिक एंटीडिप्रेसेंटमध्यम

    Close supervision and careful adjustment of dosage are required when this drug is given concomitantly with anticholinergic or sympathomimetic drugs. (डेसिप्रामिन लेबल, दवाओं के इंटरैक्शन)

  • Drug Interactions Administration of doxapram to patients who are receiving sympathomimetic or monoamine oxidase inhibiting drugs may result in an additive pressor effect (see PRECAUTIONS, General ). (डॉक्साप्राम लेबल, दवाओं के इंटरैक्शन)

  • डोरज़ोलामाइड और टिमोलोलकार्बोनिक एनहाइड्रेज़ इनहिबिटरमध्यम

    If necessary during surgery, the effects of beta-adrenergic blocking agents may be reversed by sufficient doses of adrenergic agonists. (डोरज़ोलामाइड और टिमोलोल लेबल, चेतावनियां और सावधानियां)

  • ड्रॉक्सीडोपासिम्पैथोमिमेटिकमध्यम

    The risk of hypertension increases with concomitant administration of drugs that increase blood pressure (phenylephrine, pseudoephedrine, ephedrine, dihydroergotamine, thyroid hormones, or droxidopa). (मिडोड्रिन लेबल, दवाओं के इंटरैक्शन)

  • नेटेग्लिनाइडमेग्लिटिनाइडमध्यम

    Drugs and Herbals That May Reduce the Blood-Glucose-Lowering Effect of Nateglinide and Increase Susceptibility to Hyperglycemia Drugs: Thiazides, corticosteroids, thyroid products, sympathomimetics, somatropin, somatostatin analogues (e.g., lanreotide, octreotide), and CYP inducers (e.g., rifampin, phenytoin and St John's Wort). (नेटेग्लिनाइड लेबल, दवाओं के इंटरैक्शन)

  • नॉरट्रिप्टिलीनट्राइसाइक्लिक एंटीडिप्रेसेंटमध्यम

    Close supervision and careful adjustment of the dosage are required when Pamelor is used with other anticholinergic drugs and sympathomimetic drugs. (नॉरट्रिप्टिलीन लेबल, दवाओं के इंटरैक्शन)

  • पियोग्लिटाज़ोन और ग्लिमेपिराइडथायज़ोलिडिनडायोनमध्यम

    …somatropin, protease inhibitors, atypical antipsychotic medications (e.g., olanzapine and clozapine), barbiturates, diazoxide, laxatives, rifampin, thiazides and other diuretics, corticosteroids, phenothiazines, thyroid hormones, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics (e.g., epinephrine, albuterol, terbutaline), and isoniazid. (पियोग्लिटाज़ोन और ग्लिमेपिराइड लेबल, दवाओं के इंटरैक्शन)

  • प्रोट्रिप्टिलीनट्राइसाइक्लिक एंटीडिप्रेसेंटमध्यम

    Drug Interactions When protriptyline is given with anticholinergic agents or sympathomimetic drugs, including epinephrine combined with local anesthetics, close supervision and careful adjustment of dosages are required. (प्रोट्रिप्टिलीन लेबल, दवाओं के इंटरैक्शन)

  • प्रोपाइलथायोयूरेसिलएंटीथायरॉइड दवामध्यम

    The risk of hypertension increases with concomitant administration of drugs that increase blood pressure (phenylephrine, pseudoephedrine, ephedrine, dihydroergotamine, thyroid hormones, or droxidopa). (मिडोड्रिन लेबल, दवाओं के इंटरैक्शन)

  • प्रोप्रानोलोलबीटा ब्लॉकरमध्यम

    Pharmacodynamic Drug-Drug Interactions Adrenergic Agonists: Beta-blockers may antagonize the antihypertensive effects of clonidine, and rebound hypertension may result if clonidine is withdrawn abruptly. (प्रोप्रानोलोल लेबल, दवाओं के इंटरैक्शन)

  • फिनाइलएफ्रिनडीकंजेस्टेंटमध्यम

    The risk of hypertension increases with concomitant administration of drugs that increase blood pressure (phenylephrine, pseudoephedrine, ephedrine, dihydroergotamine, thyroid hormones, or droxidopa). (मिडोड्रिन लेबल, दवाओं के इंटरैक्शन)

  • फ्लुड्रोकॉर्टिसोनकॉर्टिकोस्टेरॉइडमध्यम

    The potential for supine hypertension should be carefully monitored in these patients and may be minimized by either reducing the dose of fludrocortisone acetate or decreasing the salt intake prior to initiation of treatment with midodrine hydrochloride. (मिडोड्रिन लेबल, दवाओं के इंटरैक्शन)

  • Management of orthostatic/postural hypotension may include adjustment of antihypertensive medications, hydration, and administration of mineralocorticoids and/or sympathomimetics. (बोर्टेज़ोमिब लेबल, चेतावनियां और सावधानियां)

  • ब्रिमोनिडिन और टिमोलोलअल्फा-एड्रीनर्जिक एगोनिस्टमध्यम

    If necessary during surgery, the effects of beta-adrenergic blocking agents may be reversed by sufficient doses of adrenergic agonists. (ब्रिमोनिडिन और टिमोलोल लेबल, चेतावनियां और सावधानियां)

  • The risk of hypertension increases with concomitant administration of drugs that increase blood pressure (phenylephrine, pseudoephedrine, ephedrine, dihydroergotamine, thyroid hormones, or droxidopa). (मिडोड्रिन लेबल, दवाओं के इंटरैक्शन)

  • मिथाइलडोपाएंटीहाइपरटेंसिव (ब्लड प्रेशर की दवा)मध्यम

    If hypotension does occur during anesthesia, it usually can be controlled by vasopressors. (मिथाइलडोपा लेबल, दवाओं के इंटरैक्शन)

  • मेटोलाज़ोनथायज़ाइड डाइयूरेटिकमध्यम

    Sympathomimetics Metolazone may decrease arterial responsiveness to norepinephrine, but this diminution is not sufficient to preclude effectiveness of the pressor agent for therapeutic use. (मेटोलाज़ोन लेबल, दवाओं के इंटरैक्शन)

  • मेथिमाज़ोलएंटीथायरॉइड दवामध्यम

    The risk of hypertension increases with concomitant administration of drugs that increase blood pressure (phenylephrine, pseudoephedrine, ephedrine, dihydroergotamine, thyroid hormones, or droxidopa). (मिडोड्रिन लेबल, दवाओं के इंटरैक्शन)

  • लिडोकेनलोकल एनेस्थेटिकमध्यम

    Concurrent administration of vasopressor drugs (for the treatment of hypotension related to obstetric blocks) and ergot-type oxytocic drugs may cause severe, persistent hypertension or cerebrovascular accidents. (लिडोकेन लेबल, दवाओं के इंटरैक्शन)

  • लिसडेक्सएम्फेटामाइनCNS स्टिमुलेंटमध्यम

    Tricyclic Antidepressants Clinical Impact May enhance the activity of tricyclic or sympathomimetic agents causing striking and sustained increases in the concentration of d-amphetamine in the brain; cardiovascular effects can be potentiated. (लिसडेक्सएम्फेटामाइन लेबल, दवाओं के इंटरैक्शन)

  • लेवोथायरोक्सिनथायरॉइड हार्मोनमध्यम

    The risk of hypertension increases with concomitant administration of drugs that increase blood pressure (phenylephrine, pseudoephedrine, ephedrine, dihydroergotamine, thyroid hormones, or droxidopa). (मिडोड्रिन लेबल, दवाओं के इंटरैक्शन)

  • Circulatory Shock Circulatory shock with fever, severe hypotension, and confusion requiring intravenous fluid resuscitation and vasopressors has occurred within minutes to hours of re-challenge with trimethoprim-sulfamethoxazole products in patients with history of recent (days to weeks) exposure to sulfamethoxazole and trimethoprim. (सल्फामेथॉक्साज़ोल और ट्राइमेथोप्रिम लेबल, चेतावनियां)

  • The most commonly described clinical features in reports of anaphylaxis were dermatologic symptoms (including urticaria, rash, erythema, flushing and skin eruption); and clinically important hypotension often requiring the use of vasopressors for circulatory support. (सुगैमाडेक्स लेबल, चेतावनियां और सावधानियां)

  • स्यूडोएफेड्रिनडीकंजेस्टेंटमध्यम

    The risk of hypertension increases with concomitant administration of drugs that increase blood pressure (phenylephrine, pseudoephedrine, ephedrine, dihydroergotamine, thyroid hormones, or droxidopa). (मिडोड्रिन लेबल, दवाओं के इंटरैक्शन)

मामूली ज़िक्र (60)

  • अल्फुज़ोसिनअल्फा ब्लॉकरमामूली

    Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of midodrine hydrochloride. (मिडोड्रिन लेबल, दवाओं के इंटरैक्शन)

  • इप्राट्रोपियमएंटीकोलिनर्जिकमामूली

    ATROVENT HFA has been used concomitantly with other drugs, including sympathomimetic bronchodilators, methylxanthines, oral and inhaled steroids commonly used in the treatment of COPD. (इप्राट्रोपियम लेबल, दवाओं के इंटरैक्शन)

  • एकार्बोज़एंटीडायबिटिक (डायबिटीज़ की दवा)मामूली

    These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel-blocking drugs, and isoniazid. (एकार्बोज़ लेबल, दवाओं के इंटरैक्शन)

  • एज़ेलास्टिन और फ्लुटिकासोनएंटीहिस्टामिनमामूली

    Midodrine hydrochloride has been used in patients concomitantly treated with salt-retaining steroid therapy (i.e., fludrocortisone acetate), with or without salt supplementation. (मिडोड्रिन लेबल, दवाओं के इंटरैक्शन)

  • …for Drug Interaction: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, flecainide, and quinidine. (मिडोड्रिन लेबल, सावधानियां)

  • एर्गोटामिन और कैफीनएर्गोट एल्कलॉइडमामूली

    Use with sympathomimetics (pressor agents) may cause extreme elevation of blood pressure. (एर्गोटामिन और कैफीन लेबल, दवाओं के इंटरैक्शन)

  • ऑक्सीमेटाज़ोलिनडीकंजेस्टेंटमामूली

    Alpha-adrenergic agonists as a class may impact blood pressure. (ऑक्सीमेटाज़ोलिन लेबल, चेतावनियां और सावधानियां)

  • ओलोपाटाडीन और मोमेटासोनएंटीहिस्टामिनमामूली

    Midodrine hydrochloride has been used in patients concomitantly treated with salt-retaining steroid therapy (i.e., fludrocortisone acetate), with or without salt supplementation. (मिडोड्रिन लेबल, दवाओं के इंटरैक्शन)

  • कार्वेडिलोलबीटा ब्लॉकरमामूली

    Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of midodrine hydrochloride. (मिडोड्रिन लेबल, दवाओं के इंटरैक्शन)

  • क्लोबेटासोलकॉर्टिकोस्टेरॉइडमामूली

    Midodrine hydrochloride has been used in patients concomitantly treated with salt-retaining steroid therapy (i.e., fludrocortisone acetate), with or without salt supplementation. (मिडोड्रिन लेबल, दवाओं के इंटरैक्शन)

  • क्विनिडिनएंटीएरिदमिकमामूली

    …for Drug Interaction: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, flecainide, and quinidine. (मिडोड्रिन लेबल, सावधानियां)

  • ग्लिपिज़ाइड और मेटफॉर्मिनसल्फोनिलयूरियामामूली

    …for Drug Interaction: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, flecainide, and quinidine. (मिडोड्रिन लेबल, सावधानियां)

  • ग्लिबेनक्लामाइडसल्फोनिलयूरियामामूली

    These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid. (ग्लिबेनक्लामाइड लेबल, दवाओं के इंटरैक्शन)

  • ग्लिबेनक्लामाइड और मेटफॉर्मिनसल्फोनिलयूरियामामूली

    …for Drug Interaction: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, flecainide, and quinidine. (मिडोड्रिन लेबल, सावधानियां)

  • टेराज़ोसिनअल्फा ब्लॉकरमामूली

    Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of midodrine hydrochloride. (मिडोड्रिन लेबल, दवाओं के इंटरैक्शन)

  • टैम्सुलोसिनअल्फा ब्लॉकरमामूली

    Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of midodrine hydrochloride. (मिडोड्रिन लेबल, दवाओं के इंटरैक्शन)

  • ट्राइमिप्रामिनट्राइसाइक्लिक एंटीडिप्रेसेंटमामूली

    Therefore, particular care should be exercised when it is necessary to administer tricyclic antidepressants with sympathomimetic amines, local decongestants, local anesthetics containing epinephrine, atropine or drugs with an anticholinergic effect. (ट्राइमिप्रामिन लेबल, दवाओं के इंटरैक्शन)

  • ट्रायमटेरिनपोटैशियम-स्पेयरिंग डाइयूरेटिकमामूली

    …for Drug Interaction: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, flecainide, and quinidine. (मिडोड्रिन लेबल, सावधानियां)

  • ट्रायमटेरिन और हाइड्रोक्लोरोथायज़ाइडपोटैशियम-स्पेयरिंग डाइयूरेटिकमामूली

    …for Drug Interaction: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, flecainide, and quinidine. (मिडोड्रिन लेबल, सावधानियां)

  • ट्रायमसिनोलोनकॉर्टिकोस्टेरॉइडमामूली

    Midodrine hydrochloride has been used in patients concomitantly treated with salt-retaining steroid therapy (i.e., fludrocortisone acetate), with or without salt supplementation. (मिडोड्रिन लेबल, दवाओं के इंटरैक्शन)

  • डेक्सट्रोमेथॉर्फन और क्विनिडिनसेरोटोनर्जिक दवामामूली

    …for Drug Interaction: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, flecainide, and quinidine. (मिडोड्रिन लेबल, सावधानियां)

  • डेक्सामेथासोनकॉर्टिकोस्टेरॉइडमामूली

    Midodrine hydrochloride has been used in patients concomitantly treated with salt-retaining steroid therapy (i.e., fludrocortisone acetate), with or without salt supplementation. (मिडोड्रिन लेबल, दवाओं के इंटरैक्शन)

  • डेफ्लाज़ाकॉर्टकॉर्टिकोस्टेरॉइडमामूली

    Midodrine hydrochloride has been used in patients concomitantly treated with salt-retaining steroid therapy (i.e., fludrocortisone acetate), with or without salt supplementation. (मिडोड्रिन लेबल, दवाओं के इंटरैक्शन)

  • डेसोनाइडकॉर्टिकोस्टेरॉइडमामूली

    Midodrine hydrochloride has been used in patients concomitantly treated with salt-retaining steroid therapy (i.e., fludrocortisone acetate), with or without salt supplementation. (मिडोड्रिन लेबल, दवाओं के इंटरैक्शन)

  • …for Drug Interaction: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, flecainide, and quinidine. (मिडोड्रिन लेबल, सावधानियां)

  • डॉक्साज़ोसिनअल्फा ब्लॉकरमामूली

    Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of midodrine hydrochloride. (मिडोड्रिन लेबल, दवाओं के इंटरैक्शन)

  • ड्यूटास्टेराइड और टैम्सुलोसिन5-अल्फा रिडक्टेज़ इनहिबिटरमामूली

    Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of midodrine hydrochloride. (मिडोड्रिन लेबल, दवाओं के इंटरैक्शन)

  • परफेनाज़िनएंटीसाइकोटिकमामूली

    If a vasopressor is needed, norepinephrine may be used. (परफेनाज़िन लेबल, चेतावनियां)

  • पियोग्लिटाज़ोन और मेटफॉर्मिनथायज़ोलिडिनडायोनमामूली

    …for Drug Interaction: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, flecainide, and quinidine. (मिडोड्रिन लेबल, सावधानियां)

  • प्राज़ोसिनअल्फा ब्लॉकरमामूली

    Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of midodrine hydrochloride. (मिडोड्रिन लेबल, दवाओं के इंटरैक्शन)

  • प्रेडनिसोनकॉर्टिकोस्टेरॉइडमामूली

    Midodrine hydrochloride has been used in patients concomitantly treated with salt-retaining steroid therapy (i.e., fludrocortisone acetate), with or without salt supplementation. (मिडोड्रिन लेबल, दवाओं के इंटरैक्शन)

  • प्रेडनिसोलोनकॉर्टिकोस्टेरॉइडमामूली

    Midodrine hydrochloride has been used in patients concomitantly treated with salt-retaining steroid therapy (i.e., fludrocortisone acetate), with or without salt supplementation. (मिडोड्रिन लेबल, दवाओं के इंटरैक्शन)

  • प्रोकेनामाइडएंटीएरिदमिकमामूली

    …for Drug Interaction: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, flecainide, and quinidine. (मिडोड्रिन लेबल, सावधानियां)

  • प्रोपोफोलCNS डिप्रेसेंटमामूली

    These effects are responsive to discontinuation of DIPRIVAN, intravenous fluid administration, and/or vasopressor therapy. (प्रोपोफोल लेबल, चेतावनियां और सावधानियां)

  • फेंटोलामिनअल्फा ब्लॉकरमामूली

    Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of midodrine hydrochloride. (मिडोड्रिन लेबल, दवाओं के इंटरैक्शन)

  • फेनोक्सीबेंज़ामिनअल्फा ब्लॉकरमामूली

    Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of midodrine hydrochloride. (मिडोड्रिन लेबल, दवाओं के इंटरैक्शन)

  • फ्लुओसिनोनाइडकॉर्टिकोस्टेरॉइडमामूली

    Midodrine hydrochloride has been used in patients concomitantly treated with salt-retaining steroid therapy (i.e., fludrocortisone acetate), with or without salt supplementation. (मिडोड्रिन लेबल, दवाओं के इंटरैक्शन)

  • फ्लुटिकासोनकॉर्टिकोस्टेरॉइडमामूली

    Midodrine hydrochloride has been used in patients concomitantly treated with salt-retaining steroid therapy (i.e., fludrocortisone acetate), with or without salt supplementation. (मिडोड्रिन लेबल, दवाओं के इंटरैक्शन)

  • फ्लुनिसोलाइडकॉर्टिकोस्टेरॉइडमामूली

    Midodrine hydrochloride has been used in patients concomitantly treated with salt-retaining steroid therapy (i.e., fludrocortisone acetate), with or without salt supplementation. (मिडोड्रिन लेबल, दवाओं के इंटरैक्शन)

  • फ्लेकेनाइडएंटीएरिदमिकमामूली

    …for Drug Interaction: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, flecainide, and quinidine. (मिडोड्रिन लेबल, सावधानियां)

  • बीटामेथासोनकॉर्टिकोस्टेरॉइडमामूली

    Midodrine hydrochloride has been used in patients concomitantly treated with salt-retaining steroid therapy (i.e., fludrocortisone acetate), with or without salt supplementation. (मिडोड्रिन लेबल, दवाओं के इंटरैक्शन)

  • बुडेसोनाइडकॉर्टिकोस्टेरॉइडमामूली

    Midodrine hydrochloride has been used in patients concomitantly treated with salt-retaining steroid therapy (i.e., fludrocortisone acetate), with or without salt supplementation. (मिडोड्रिन लेबल, दवाओं के इंटरैक्शन)

  • Severe reactions have required intervention with vasopressor agents and supportive measures. (बेंज़ोनाटेट लेबल, चेतावनियां)

  • बेक्लोमेथासोनकॉर्टिकोस्टेरॉइडमामूली

    Midodrine hydrochloride has been used in patients concomitantly treated with salt-retaining steroid therapy (i.e., fludrocortisone acetate), with or without salt supplementation. (मिडोड्रिन लेबल, दवाओं के इंटरैक्शन)

  • ब्रोमोक्रिप्टिनडोपामिन एगोनिस्टमामूली

    There are postmarketing reports of hypertension and tachycardia when bromocriptine was co-administered with sympathomimetic drugs (e.g., phenylpropanolamine and isometheptene) in postpartum women. (ब्रोमोक्रिप्टिन लेबल, दवाओं के इंटरैक्शन)

  • मिथाइलप्रेडनिसोलोनकॉर्टिकोस्टेरॉइडमामूली

    Midodrine hydrochloride has been used in patients concomitantly treated with salt-retaining steroid therapy (i.e., fludrocortisone acetate), with or without salt supplementation. (मिडोड्रिन लेबल, दवाओं के इंटरैक्शन)

  • मेटफॉर्मिनबाइगुआनाइडमामूली

    …for Drug Interaction: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, flecainide, and quinidine. (मिडोड्रिन लेबल, सावधानियां)

  • मोमेटासोनकॉर्टिकोस्टेरॉइडमामूली

    Midodrine hydrochloride has been used in patients concomitantly treated with salt-retaining steroid therapy (i.e., fludrocortisone acetate), with or without salt supplementation. (मिडोड्रिन लेबल, दवाओं के इंटरैक्शन)

  • Atypical Antipsychotics (e.g., olanzapine and clozapine), Corticosteroids, Danazol, Diuretics, Estrogens, Glucagon, Isoniazid, Niacin, Oral Contraceptives, Phenothiazines, Progestogens (e.g., in oral contraceptives), Protease inhibitors, Somatropin, Sympathomimetic Agents (e.g., albuterol, epinephrine, terbutaline) and Thyroid Hormones. (रेगुलर इंसुलिन (ह्यूमन) लेबल, दवाओं के इंटरैक्शन)

  • रेपाग्लिनाइडमेग्लिटिनाइडमामूली

    …antipsychotics (e.g., olanzapine and clozapine), calcium channel antagonists, corticosteroids, danazol, diuretics, estrogens, glucagon, isoniazid, niacin, oral contraceptives, phenothiazines, progestogens (e.g., in oral contraceptives), protease inhibitors, somatropin, sympathomimetic agents (e.g., albuterol, epinephrine, terbutaline), and thyroid hormones. (रेपाग्लिनाइड लेबल, दवाओं के इंटरैक्शन)

  • रैनिटिडीनH2 ब्लॉकरमामूली

    …for Drug Interaction: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, flecainide, and quinidine. (मिडोड्रिन लेबल, सावधानियां)

  • …for Drug Interaction: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, flecainide, and quinidine. (मिडोड्रिन लेबल, सावधानियां)

  • लेबेटालोलबीटा ब्लॉकरमामूली

    Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of midodrine hydrochloride. (मिडोड्रिन लेबल, दवाओं के इंटरैक्शन)

  • सिक्लेसोनाइडकॉर्टिकोस्टेरॉइडमामूली

    Midodrine hydrochloride has been used in patients concomitantly treated with salt-retaining steroid therapy (i.e., fludrocortisone acetate), with or without salt supplementation. (मिडोड्रिन लेबल, दवाओं के इंटरैक्शन)

  • …for Drug Interaction: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, flecainide, and quinidine. (मिडोड्रिन लेबल, सावधानियां)

  • सिमेटिडीनH2 ब्लॉकरमामूली

    …for Drug Interaction: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, flecainide, and quinidine. (मिडोड्रिन लेबल, सावधानियां)

  • सिलोडोसिनअल्फा ब्लॉकरमामूली

    Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of midodrine hydrochloride. (मिडोड्रिन लेबल, दवाओं के इंटरैक्शन)

  • …for Drug Interaction: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, flecainide, and quinidine. (मिडोड्रिन लेबल, सावधानियां)

  • हाइड्रोकॉर्टिसोनकॉर्टिकोस्टेरॉइडमामूली

    Midodrine hydrochloride has been used in patients concomitantly treated with salt-retaining steroid therapy (i.e., fludrocortisone acetate), with or without salt supplementation. (मिडोड्रिन लेबल, दवाओं के इंटरैक्शन)

  • हेलोबेटासोलकॉर्टिकोस्टेरॉइडमामूली

    Midodrine hydrochloride has been used in patients concomitantly treated with salt-retaining steroid therapy (i.e., fludrocortisone acetate), with or without salt supplementation. (मिडोड्रिन लेबल, दवाओं के इंटरैक्शन)

आप जो कुछ भी लेते हैं, उस सबके साथ मिडोड्रिन को जांचें। अपनी पूरी सूची जोड़ें; हर जोड़ी एक साथ जांची जाती है।

चेकर में खोलें

यह चिकित्सकीय सलाह नहीं है। गंभीरता लेबल के शब्दों को दर्शाती है, आपकी परिस्थितियों को नहीं। “गंभीर” चिह्न वाला संयोजन डॉक्टर की देखरेख में सामान्य बात हो सकता है, और “मामूली” चिह्न वाला संयोजन ऊंची खुराक पर मायने रख सकता है। फार्मासिस्ट से पूछें।